SLXN
Silexion Therapeutics Corp Ordinary Shares
SLXN
SLXN
5 hedge funds and large institutions have $613K invested in Silexion Therapeutics Corp Ordinary Shares in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WCM
1
Wildcat Capital Management
New York
|
$536K |
| 2 |
HF
2
HRT Financial
New York
|
$47K |
| 3 |
VF
3
Virtu Financial
New York
|
$14K |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$7.94K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$7.91K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WCM
1
Wildcat Capital Management
New York
| $536K | +$536K | +7,562 | New |
|
|
HF
2
HRT Financial
New York
| $47K | +$47K | +666 | New |
|
|
VF
3
Virtu Financial
New York
| $14K | +$14K | +197 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $7.94K | +$7.94K | +112 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $7.91K | +$7.91K | +112 | New |
|